Stay updated with breaking news from Optimum Regimen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference Pratteln, Switzerland, and Rockville, MD, USA, June 9, 2022 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of new data with vamorolone in Duchenne mus...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Pratteln, Switzerland, and Rockville, MD, USA, June 9, 2022 - Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce presentations of new data with vamorolone in Duchenne muscular
New research published in JAMA recommends daily steroid doses for children with Duchenne muscular dystrophy (DMD), marking a significant change in how the disease is treated.
Daily steroids are not only safe for children with Duchenne muscular dystrophy, they also slow the disease's progression, a new study shows.